跳至主要内容
临床试验/NCT01812356
NCT01812356已完成不适用

Study of Cryomaze Procedure Using Nitrous Oxide Versus Argon Gas

Samsung Medical Center2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2013年3月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
recurrence of atrial fibrillation

研究概览

简要总结

The aim of this study is compare the surgical convenience and early and long-term outcomes of cryomaze procedure using nitrous oxide with using Argon gas.

The investigators will analyze the pathologic findings of atrial tissue after cryoablation using two probes and early and long-term outcomes with Holter monitoring. Atrial fibrillation burden 3 months and 1 year postoperatively and atrial activity will be checked.

详细描述

The investigators have used the Medtronic ATS cryoprobe (Argon based) since 2009 for cryomaze procedure for treatment of atrial fibrillation combined with valvular heart disease.

However, sometimes, it was inconvenient due to excess flexibility, wide lesion related to excess low temperature and time-consuming detachment from atrium after cryoablation. The investigators introduced Atricure cryoprobe (Nitreos Oxide based) in hope of overcoming these shortcomings of ATS probes last year.

Up to date, the investigators have been satisfactory in terms of the surgical convenience. On the other hand, we have the questionability of transmural lesion of Atricure probe because of the higher temperature of Atricure probe compared with ATS probe.

The aim of this study is compare the surgical convenience and early and long-term outcomes of cryomaze procedure using nitrous oxide with using Argon gas.

The investigators will analyze the pathologic findings of atrial tissue after cryoablation using two probes and early and long-term outcomes with Holter monitoring. Atrial fibrillation burden 3 months and 1 year postoperatively and atrial activity will be checked.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • requiring concomitant maze operation with valve surgery (persistent atrial fibrillation)
  • between 18 and 75 years old

排除标准

  • previous cardiac surgery
  • Behcet disease
  • Takayasu's arteritis
  • Infective endocarditis
  • Congenital heart disease
  • left atrial size over 80mm
  • moderate or greater functional tricuspid regurgitation

研究组 & 干预措施

Argon gas probe

Experimental

Cryomaze procedure using Argon gas probe

干预措施: Cryomaze procedure using Argon (Device)

Nitrous oxide probe

Active Comparator

Cryomaze procedure using Nitrous oxide probe

干预措施: Cryomaze procedure using Nitrous oxide (Device)

结局指标

主要结局

recurrence of atrial fibrillation

时间窗: one year

Treatment failure

次要结局

  • Postoperative stroke(one year)
  • Atrial arrhythmia events(one year)
  • Cardiac related death(one year)
  • heart failure(one year)
  • Reoperation(one year)
  • Intracranial hemorrhage(one year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验